DURECT
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DURECT and buy or sell other stocks, ETFs, and their options commission-free!About DRRX
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.
CEOJames E. Brown, DVM
CEOJames E. Brown, DVM
Employees31
Employees31
HeadquartersCupertino, California
HeadquartersCupertino, California
Founded1998
Founded1998
Employees31
Employees31
DRRX Key Statistics
Market cap23.17M
Market cap23.17M
Price-Earnings ratio-4.09
Price-Earnings ratio-4.09
Dividend yield—
Dividend yield—
Average volume521.17K
Average volume521.17K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.64
52 Week high$2.64
52 Week low$0.4801
52 Week low$0.4801
Stock Snapshot
As of today, DURECT(DRRX) shares are valued at $0.75. The company's market cap stands at 23.17M, with a P/E ratio of -4.09.
DURECT(DRRX) stock opened on 2025-12-25 at —. The price climbed to — and dipped to —.
DURECT(DRRX) shares are trading with a volume of 0, against a daily average of 521.17K.
In the last year, DURECT(DRRX) shares hit a 52-week high of $2.64 and a 52-week low of $0.48.
In the last year, DURECT(DRRX) shares hit a 52-week high of $2.64 and a 52-week low of $0.48.
People also own
Based on the portfolios of people who own DRRX. This list is generated using Robinhood data, and it’s not a recommendation.